Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY)
Clinical trial NCT03018340 · COMPLETED
Trial details
- NCT number
- NCT03018340
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2018-09-01
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.